Huons logo

Huons

Asia, Kyonggi-do, South Korea, Seongnam

Description

Huons is a medical solution for human health.

Investor Profile

Huons has made 2 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (50%)
  • Seed (50%)

Country Focus

  • United States (50%)
  • South Korea (50%)

Industry Focus

  • Biotechnology
  • Genetics
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Huons frequently co-invest with?

Dong-A ST
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
PP
North America, Michigan, United States, Rochester Hills
Co-Investments: 1
Korea Development Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Terra VC
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1
KIMCO
Asia, Seoul-t'ukpyolsi, South Korea, Seocho
Co-Investments: 1
loftyrock investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
A
North America, New York, United States, New York
Co-Investments: 1
K2 Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Huons?

Aliad Biopharma

Seoul, Seoul-t'ukpyolsi, South Korea

Aliad Biopharma focuses on the development of nerve disease treatments designed for Alzheimer's disease and autism spectrum disorders.

BiopharmaBiotechnologyHealth Care
SeedNov 15, 2024
GenEdit

South San Francisco, California, United States

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

BiotechnologyGeneticsPharmaceuticalTherapeutics
Series AJan 23, 2024
Amount Raised: $24,000,000